{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:47:36Z","timestamp":1790891256386,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["861323"],"award-info":[{"award-number":["861323"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijantimicag.2025.107476","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:43:48Z","timestamp":1740098628000},"page":"107476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interspecies differences in plasma protein binding of beta-lactam antibiotics"],"prefix":"10.1016","volume":"65","author":[{"given":"Hifza","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Dorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107476_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.888079","article-title":"The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug development and their influence on the success of agents developed to combat resistant gram negative pathogens: A review","volume":"13","author":"Palmer","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0002","first-page":"923","article-title":"Protein binding in translational antimicrobial development-focus on interspecies differences","volume":"11","author":"Ahmed","year":"2022","journal-title":"Antibiot Basel Switz"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01647-23","article-title":"Interspecies variability in protein binding of antibiotics basis for translational PK\/PD studies-a case study using cefazolin","volume":"68","author":"Ahmed","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0004","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/phar.2476","article-title":"Cefiderocol: A novel siderophore cephalosporin against multidrug-resistant gram-negative pathogens","volume":"40","author":"Abdul-Mutakabbir","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0005","first-page":"900","article-title":"Ceftriaxone: A third-generation cephalosporin","volume":"19","author":"McLeod","year":"1985","journal-title":"Drug Intell Clin Pharm"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0006","first-page":"493","article-title":"Temocillin: Applications in antimicrobial stewardship as a potential carbapenem-sparing antibiotic","volume":"11","author":"Lupia","year":"2022","journal-title":"Antibiot Basel Switz"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0007","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/jac\/dkaa176","article-title":"Single-dose pharmacokinetics of temocillin in plasma and soft tissues of healthy volunteers after intravenous and subcutaneous administration: A randomized crossover microdialysis trial","volume":"75","author":"Matzneller","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0008","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.drudis.2011.12.018","article-title":"Compilation of 222 drugs\u2019 plasma protein binding data and guidance for study designs","volume":"17","author":"Zhang","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0009","doi-asserted-by":"crossref","first-page":"S552","DOI":"10.1093\/cid\/ciz828","article-title":"Pharmacokinetic and pharmacodynamic profiles of cefiderocol, a novel siderophore cephalosporin","volume":"69","author":"Katsube","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0010","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1128\/AAC.37.7.1518","article-title":"Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges","volume":"37","author":"Nau","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0011","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1093\/jac\/dkae359","article-title":"Target-site cefiderocol pharmacokinetics in soft tissues of healthy volunteers","volume":"79","author":"Sanz-Codina","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1200828","article-title":"Physiologically-based pharmacokinetic modeling for single and multiple dosing regimens of ceftriaxone in healthy and chronic kidney disease populations: A tool for model-informed precision dosing","volume":"14","author":"Alasmari","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0013","first-page":"458","article-title":"Stability studies of 16 antibiotics for continuous infusion in intensive care units and for performing outpatient parenteral antimicrobial therapy","volume":"11","author":"Loeuille","year":"2022","journal-title":"Antibiot Basel Switz"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0014","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/jac\/dkad251","article-title":"Stability of temocillin in outpatient parenteral antimicrobial therapy: Is it a real option?","volume":"78","author":"Fern\u00e1ndez-Rubio","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0015","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3390\/antibiotics12030432","article-title":"Stability of ampicillin plus ceftriaxone combined in elastomeric infusion devices for outpatient parenteral antimicrobial therapy","volume":"12","author":"Fern\u00e1ndez-Rubio","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0016","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/jac\/dkac400","article-title":"Comparison of ultrafiltration and microdialysis for ceftriaxone protein-binding determination","volume":"78","author":"Sanz-Codina","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0017","doi-asserted-by":"crossref","first-page":"S538","DOI":"10.1093\/cid\/ciz826","article-title":"Cefiderocol: Discovery, chemistry, and in vivo profiles of a novel siderophore cephalosporin","volume":"69","author":"Sato","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.900551","article-title":"An overview of the protein binding of cephalosporins in human body fluids: a systematic review","volume":"13","author":"Jongmans","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0019","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1248\/bpb.b23-00469","article-title":"Effect of ceftriaxone dosage and albumin\u2013bilirubin score on the risk of ceftriaxone-induced liver injury","volume":"46","author":"Ooi","year":"2023","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.ijantimicag.2025.107476_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1359-6101(02)00054-0","article-title":"\u03b11-Acid glycoprotein: An acute phase protein with inflammatory and immunomodulating properties","volume":"14","author":"Hochepied","year":"2003","journal-title":"Cytokine Growth Factor Rev"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925000305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T07:10:23Z","timestamp":1744269023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925000305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0924857925000305"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107476","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interspecies differences in plasma protein binding of beta-lactam antibiotics","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107476"}}